New analysis reveals millions could avoid heart attacks with inclisiran
NCT ID NCT07214857
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study used national health survey data to estimate how many US adults with high cholesterol might be eligible for the drug inclisiran, and how many heart attacks or strokes could be prevented over 10 years. Researchers analyzed information from over 1,300 participants to identify those with elevated LDL cholesterol despite taking statins. The goal was to understand the potential public health impact of inclisiran, not to test the drug itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.